Analysis of histology-agnostic targets among soft tissue and bone sarcomas in the AACR GENIE database
BackgroundThe development of novel therapies for patients with sarcoma is challenging due to the rarity and diversity of these mesenchymal neoplasms. Hence, histology-agnostic approvals can be of particular interest for the treatment of patients with soft tissue and bone sarcoma.MethodsWe queried th...
Main Authors: | Roberto Carmagnani Pestana, César Serrano |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1079909/full |
Similar Items
-
The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer
by: Giovanni Maria Iannantuono, et al.
Published: (2022-08-01) -
The Safety Profiles of Two First-Generation NTRK Inhibitors: Analysis of Individual Case Safety Reports from the FDA Adverse Event Reporting System (FAERS) Database
by: Valerio Liguori, et al.
Published: (2023-09-01) -
Understanding the Reasons That Lead Young People in Bogota to Identify as Atheist and Agnostic
by: William Mauricio Beltrán, et al.
Published: (2023-06-01) -
Application of mTORC1 Inhibitors for Tissue-Agnostic Management of Standard-Therapy-Refractory Solid Tumors
by: Hossein Taghizadeh, et al.
Published: (2022-04-01) -
A model-agnostic approach for understanding heart failure risk factors
by: Seyed M. Miran, et al.
Published: (2021-05-01)